CBChroma
ApprovedHaematology platform that counts blood cells and measures haemoglobin in about ten minutes; approved for manufacture in Korea.
FROM PUBLIC EVENTS · 2026-11-15
Early clinical · first deals Entering a new diagnostic field with approval of its haematology platform and starting local production in Brazil. Also seen: Global approvals · expansion
Roles often seen at this stageDevice R&D & support · Regulatory affairs · Sales & marketing
An in-vitro diagnostics company making point-of-care immunoassay analysers and cartridges, now expanding into haematology.
Haematology platform that counts blood cells and measures haemoglobin in about ten minutes; approved for manufacture in Korea.
Received Korean approval to manufacture the CBChroma haematology platform.
Signed a local production and supply agreement with a Brazilian diagnostics company.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.